These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 7230856)
21. Intracellular pH measurement during cardiac arrest in ventricular myocardium by Bretschneider's cardioplegic solution HTK and St. Thomas Hospital solution with and without procaine. Heinemeyer D; Belles G; Stapenhorst K Thorac Cardiovasc Surg; 1987 Feb; 35(1):48-52. PubMed ID: 2436344 [TBL] [Abstract][Full Text] [Related]
22. Dose-dependent cardiotoxic effect of amiodarone in cardioplegic solutions correlates with loss of dihydropyridine binding sites: in vitro evidence for a potentially lethal interaction with procaine. Gøtzsche LS; Pedersen EM J Cardiovasc Pharmacol; 1994 Jan; 23(1):13-23. PubMed ID: 7511725 [TBL] [Abstract][Full Text] [Related]
23. Protection of the ischemic myocardium. Volume-duration relationships and the efficacy of myocardial infusates. Jynge P; Hearse DJ; Braimbridge MV J Thorac Cardiovasc Surg; 1978 Nov; 76(5):698-705. PubMed ID: 29995 [TBL] [Abstract][Full Text] [Related]
24. Calcium antagonists and myocardial protection during cardioplegic arrest. Yamamoto F; Manning AS; Braimbridge MV; Hearse DJ Adv Myocardiol; 1985; 6():545-62. PubMed ID: 3992050 [TBL] [Abstract][Full Text] [Related]
25. Protection of the ischemic myocardium calcium-free cardioplegic infusates and the additive effects of coronary infusion and ischemia in the induction of the calcium paradox. Jynge P Thorac Cardiovasc Surg; 1980 Oct; 28(5):303-9. PubMed ID: 6161428 [TBL] [Abstract][Full Text] [Related]
26. Improved recovery of heart transplants with a specific kit of preservation solutions. Menasché P; Pradier F; Grousset C; Peynet J; Mouas C; Bloch G; Piwnica A J Thorac Cardiovasc Surg; 1993 Feb; 105(2):353-63. PubMed ID: 8429664 [TBL] [Abstract][Full Text] [Related]
27. Ischemic preconditioning, cardioplegia or both? Differing approaches to myocardial and vascular protection. Kolocassides KG; Galiñanes M; Hearse DJ J Mol Cell Cardiol; 1996 Mar; 28(3):623-34. PubMed ID: 9011645 [TBL] [Abstract][Full Text] [Related]
28. Replacing potassium with nicorandil in cold St. Thomas' Hospital cardioplegia improves preservation of energetics and function in pig hearts. Steensrud T; Nordhaug D; Husnes KV; Aghajani E; Sørlie DG Ann Thorac Surg; 2004 Apr; 77(4):1391-7. PubMed ID: 15063273 [TBL] [Abstract][Full Text] [Related]
29. Protective effects of diltiazem and ryanodine against ischemia-reperfusion injury in neonatal rabbit hearts. Akita T; Abe T; Kato S; Kodama I; Toyama J J Thorac Cardiovasc Surg; 1993 Jul; 106(1):55-66. PubMed ID: 8321005 [TBL] [Abstract][Full Text] [Related]
30. Protection of the chronic hypoxic immature rat heart during global ischemia. Karck M; Ziemer G; Zoeller M; Schulte S; Juergens KD; Weisser H; Haverich A Ann Thorac Surg; 1995 Mar; 59(3):699-706. PubMed ID: 7887715 [TBL] [Abstract][Full Text] [Related]
31. Calcium antagonists and hypothermia: the temperature dependency of the negative inotropic and anti-ischemic properties of verapamil in the isolated rat heart. Hearse DJ; Yamamoto F; Shattock MJ Circulation; 1984 Sep; 70(3 Pt 2):I54-64. PubMed ID: 6744570 [TBL] [Abstract][Full Text] [Related]
32. Effects of calcium concentration, lactobionate content, and sodium/ potassium ratio of preservation solutions on resting left ventricular pressure and postreperfusion function of rabbit heterotopic heart transplants. Termignon JL; Pradier F; Petit A; Journois D; Weiss M; Mazmanian M J Heart Lung Transplant; 1995; 14(6 Pt 1):1126-35. PubMed ID: 8719460 [TBL] [Abstract][Full Text] [Related]
33. Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia. Pearl JM; Laks H; Drinkwater DC; Meneshian A; Sun B; Gates RN; Chang P J Thorac Cardiovasc Surg; 1993 Feb; 105(2):201-6. PubMed ID: 8429645 [TBL] [Abstract][Full Text] [Related]
34. [Cardioprotective effects of cariporide as an adjunct in different cardioplegic solutions: an experiment with rabbits]. Zhou RH; Long C; Liu J; Liu B Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2320-3. PubMed ID: 18036293 [TBL] [Abstract][Full Text] [Related]
35. Mechanoenergetic function and troponin T release following cardioplegic arrest induced by St Thomas' and histidine-tryptophan-ketoglutarate cardioplegia--an experimental comparative study in pigs. Aarsaether E; Stenberg TA; Jakobsen Ø; Busund R Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):635-9. PubMed ID: 19628529 [TBL] [Abstract][Full Text] [Related]
36. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia. Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170 [TBL] [Abstract][Full Text] [Related]
37. Protection of the ischemic myocardium: dose-response relationships with glucocorticoids in filtered cardioplegic solutions. Sellevold OF; Jynge P Thorac Cardiovasc Surg; 1987 Apr; 35(2):108-14. PubMed ID: 2440131 [TBL] [Abstract][Full Text] [Related]
38. Protection of the ischemic myocardium. Ultrastructural, enzymatic, and functional assessment of the efficacy of various cardioplegic infusates. Jynge P; Hearse DJ; de Leiris J; Feuvray D; Braimbridge MV J Thorac Cardiovasc Surg; 1978 Jul; 76(1):2-15. PubMed ID: 661363 [TBL] [Abstract][Full Text] [Related]
39. [Animal experiment evaluation of myocardial protection with a magnesium-asparaginate-procaine solution]. Walpoth B; Fornaro M; von Gossler W; Turina M Chir Forum Exp Klin Forsch; 1978; (1978):99-102. PubMed ID: 752612 [TBL] [Abstract][Full Text] [Related]
40. The potential hazard of particulate contamination of cardioplegic solutions. Robinson LA; Braimbridge MV; Hearse DJ J Thorac Cardiovasc Surg; 1984 Jan; 87(1):48-58. PubMed ID: 6690859 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]